Search for: "Pharmaceutical Research and Manufacturers of America" Results 221 - 240 of 410
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Aug 2021, 10:59 am by Kevin Kaufman
” Due to declining revenues, pharmaceutical manufactures may reduce their spending on research and development (R&D). [read post]
29 Sep 2011, 6:53 am by Hopkins
I mean assuming they do not do what they claim; we could have sagging all over America. [read post]
29 Sep 2011, 6:53 am by Hopkins
I mean assuming they do not do what they claim; we could have sagging all over America. [read post]
15 Oct 2008, 8:38 am
AAJ obtained emails that list attendees of a meeting between Bradshaw and the Pharmaceutical Research and Manufacturers of America (PhRMA) revealing the FDA chief counsel met with legal representatives from Pfizer, Wyeth, Eli Lilly, Berlex, Organon, Abbott Laboratories, Takeda, Sanofi-Aventis, Serono, AstraZeneca, Cephalon, Millenium, Eisai, Amgen, Astellas, GlaxoSmithKline, Bristol Myers Squibb, Johnson & Johnson, Novartis, Merck, and 3M.Less than six… [read post]
17 Oct 2015, 10:01 pm by Dan Flynn
A couple dozen of the nation’s top business lawyers from such powerful organizations as the National Association of Manufacturers, The Cato Institute, Chamber of Commerce of the United States, Washington Legal Foundation, and the Pharmaceutical Research and Manufacturers of America have all waded into Appellate Case: 15-1890 in the U.S. [read post]
2 Apr 2013, 10:33 am by Anubha Sinha
George Yu, an experienced patent litigation lawyer at Schiff Hardin LLP on the legality of reverse payment settlements in the pharmaceutical sector- a strategy wherein a patent holder pays a generic pharmaceutical manufacturer to delay or withdraw any challenges to patent validity. [read post]
26 Aug 2019, 12:09 pm
: Copyright and the Court of Justice of the European Union | South African IP researchers’ (AIPLITL) conference report – The IP and IT Law Innovation Interface | Event report - Second IP Researchers Europe Conference in Geneva | Why is there less innovation? [read post]
24 Jul 2020, 7:07 pm
It was to explain the different facets of America’s relationship with China, the massive imbalances in that relationship that have built up over decades, and the Chinese Communist Party’s designs for hegemony. [read post]
23 Oct 2006, 7:52 am
He has, after all, represented one of the nation's largest pharmaceutical manufacturers against consumers injured by one of its products and now works for an outfit, the American Enterprise Institute for Public Policy Research, that expresses little regard for the nation's courts. [read post]
22 Jan 2024, 1:16 pm by Dennis Crouch
(Amicus Curiae): Douglas Hallward-Driemeier – Ropes & Gray LLP Amici: USPTO: Kakoli Caprihan (Solicitors Office) Pharmaceutical Research and Manufacturers of America (Amicus Curiae): Jeffrey Kushan – Sidley Austin LLP Intellectual Property Owners Association (Amicus Curiae):Paul Berghoff – McDonnell Boehnen Hulbert & Berghoff LLP Biotechnology Innovation Organization (Amicus Curiae): Kevin Edward Noonan – McDonnell Boehnen… [read post]
21 Feb 2023, 12:30 pm by Holly
It was also the subject of lobbying by several organizations, including information technology companies, pharmaceutical companies and their trade association Pharmaceutical Research & Manufacturers of America (PhRMA), intellectual property law organizations, university organizations such as AUTM and the Association of American Universities, National Treasury Employees Union, and American Civil Liberties Union. [read post]
10 Aug 2020, 9:38 am by David Gallacher and Keeley A. McCarty
It may be safe to assume that when it comes to the active ingredient, “produced” means… well, “produced” – made, created, developed, manufactured – here in the United States of America. [read post]
25 Aug 2020, 2:24 pm by Colby Pastre
Second is allowing 100 percent expensing for certain industries (pharmaceuticals and robotics) that bring manufacturing back to the United States. [read post]
21 Nov 2014, 5:02 am by Terry Hart
Landmark Trade Deal at Risk Without Strong Intellectual Property Laws — “The nature of the TPP’s IP provisions matter greatly to the United States because America’s competitive advantage in the global economy increasingly lies in innovation-based industries—such as life sciences (pharmaceuticals and medical devices), information and communications technologies, digital services, music and film, aerospace, and advanced manufacturing—that… [read post]
9 Apr 2018, 7:35 am by Dennis Crouch
 17-1229 Brief for Amicus Brief amicus curiae of Pharmaceutical Research and Manufacturers of America. [read post]
28 Jun 2010, 6:55 am by Joe Consumer
   I mean, who would want to break the news to America's (former) sweetheart? [read post]
2 Oct 2022, 4:55 pm by Kurt R. Karst
After the OIG Special Fraud Alert, the Pharmaceutical Research and Manufacturers of America (PhRMA) updated its Code on Interactions with Health Care Professionals to offer updated guidance on speaker trainings, speaker programs, meals, and gifts. [read post]
4 Jun 2009, 1:34 pm
Ken Johnson, a spokesman for the Pharmaceutical Research and Manufacturers of America, said any agency plan to "disclose information about medicines during the F.D.A. review process should be carefully considered to ensure that the competitive development process remains intact to serve patients and the public health. [read post]
27 Jan 2012, 8:09 am by James F. McDonough, Jr.
Contract research and development for pharmaceuticals is performed in Hong Kong and Singapore. [read post]
7 Jan 2011, 1:15 pm by Adam Schlossman
Brief for respondent Pharmaceutical Research and Manufacturers of America Title: McNeill, Clifton T. v. [read post]